NEW YORK (GenomeWeb) — Despite sustained interest among researchers and diagnostics developers in advancing molecular tests to personalize cardiovascular care, integration of such tools into clinical practice is happening slowly where at all.
Spartan Bioscience Building Evidence for Point-of-Care PGx Testing to Guide Antiplatelet Therapy
Originally published March 12.
Roche, ACC Start Biomarker Web Portal
The company will work with the American College of Cardiology to create a clinical resource on the web for peer-reviewed biomarker information.
UPDATE: Warfarin Genetic Testing Decreases Hospitalization Rate, Study Finds
Research presented at the American College of Cardiology scientific session in Atlanta today suggests individuals who receive genetic testing early in their warfarin treatment are up to 31 percent less likely to be hospitalized than those who don't.